Ithaca, NY, United States of America

John E Kinsella



Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 84(Granted Patents)


Location History:

  • both of, Ithaca, NY (US) (1981)
  • Ithaca, NY (US) (1979 - 1993)

Company Filing History:


Years Active: 1979-1993

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of John E Kinsella

Introduction

John E Kinsella is a notable inventor based in Ithaca, NY (US). He has made significant contributions to the field of immunology, holding a total of 6 patents. His work focuses on enhancing host defense mechanisms through innovative compositions and methods.

Latest Patents

One of his latest patents is titled "Compositions and methods for the enhancement of host defense mechanisms." This invention provides immunostimulatory compositions that include an aggregate immunostimulatory amount of alkali and heat-stable protease derived from Thermomonospora fusca. The patent details the physicochemical properties of the protease, including its molecular mass, substrate specificity, reactivity, optimum activity temperature, pH range, and tolerance to ionic strength conditions. The protease exhibits a broad spectrum of activity, significantly outperforming traditional enzymes like trypsin or chymotrypsin.

Career Highlights

Throughout his career, John E Kinsella has worked with reputable organizations such as the Cornell Research Foundation Inc. and Sandoz GmbH. His expertise in protease research has positioned him as a key figure in the development of immunostimulatory therapies.

Collaborations

He has collaborated with notable colleagues, including Jayarama K Shetty and J Wesley Alexander, contributing to various research projects and advancements in the field.

Conclusion

John E Kinsella's innovative work in immunology and his numerous patents highlight his significant impact on enhancing host defense mechanisms. His contributions continue to influence the scientific community and pave the way for future advancements in immunotherapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…